Kleinschmidt JA - Search Results

1

Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6.

Grimm D, Kay MA, Kleinschmidt JA. Grimm D, et al. Among authors: kleinschmidt ja. Mol Ther. 2003 Jun;7(6):839-50. doi: 10.1016/s1525-0016(03)00095-9. Mol Ther. 2003. PMID: 12788658 Free article.

2

Novel adenovirus-based helper system to support production of recombinant parvovirus.

El-Andaloussi N, Endele M, Leuchs B, Bonifati S, Kleinschmidt J, Rommelaere J, Marchini A. El-Andaloussi N, et al. Cancer Gene Ther. 2011 Apr;18(4):240-9. doi: 10.1038/cgt.2010.73. Epub 2010 Nov 19. Cancer Gene Ther. 2011. PMID: 21102423

3

Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.

Chadeuf G, Favre D, Tessier J, Provost N, Nony P, Kleinschmidt J, Moullier P, Salvetti A. Chadeuf G, et al. J Gene Med. 2000 Jul-Aug;2(4):260-8. doi: 10.1002/1521-2254(200007/08)2:4<260::AID-JGM111>3.0.CO;2-8. J Gene Med. 2000. PMID: 10953917

4

Manufacturing and characterization of a recombinant adeno-associated virus type 8 reference standard material.

Ayuso E, Blouin V, Lock M, McGorray S, Leon X, Alvira MR, Auricchio A, Bucher S, Chtarto A, Clark KR, Darmon C, Doria M, Fountain W, Gao G, Gao K, Giacca M, Kleinschmidt J, Leuchs B, Melas C, Mizukami H, Müller M, Noordman Y, Bockstael O, Ozawa K, Pythoud C, Sumaroka M, Surosky R, Tenenbaum L, van der Linden I, Weins B, Wright JF, Zhang X, Zentilin L, Bosch F, Snyder RO, Moullier P. Ayuso E, et al. Hum Gene Ther. 2014 Nov;25(11):977-87. doi: 10.1089/hum.2014.057. Hum Gene Ther. 2014. PMID: 25275822 Free PMC article.

5

MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma.

Schoensiegel F, Paschen A, Sieger S, Eskerski H, Mier W, Rothfels H, Kleinschmidt J, Schadendorf D, Haberkorn U. Schoensiegel F, et al. Cancer Gene Ther. 2004 Jun;11(6):408-18. doi: 10.1038/sj.cgt.7700721. Cancer Gene Ther. 2004. PMID: 15118759

6

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

Girod A, Ried M, Wobus C, Lahm H, Leike K, Kleinschmidt J, Deléage G, Hallek M. Girod A, et al. Nat Med. 1999 Sep;5(9):1052-6. doi: 10.1038/12491. Nat Med. 1999. PMID: 10470084

7

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

Girod A, Ried M, Wobus C, Lahm H, Leike K, Kleinschmidt J, Deléage G, Hallek M. Girod A, et al. Nat Med. 1999 Dec;5(12):1438. doi: 10.1038/71021. Nat Med. 1999. PMID: 10581091 No abstract available.

8

Improved efficacy of chemotherapy by parvovirus-mediated sensitisation of human tumour cells.

Klein-Bauernschmitt P, von Knebel Doeberitz M, Ehrbar M, Geletneky K, Kleinschmidt J, Schlehofer JR. Klein-Bauernschmitt P, et al. Eur J Cancer. 1996 Sep;32A(10):1774-80. doi: 10.1016/0959-8049(96)00175-x. Eur J Cancer. 1996. PMID: 8983289

9

Measuring the outcome of health resort programs.

Weigl M, Ewert T, Kleinschmidt J, Stucki G. Weigl M, et al. J Rheumatol. 2006 Apr;33(4):764-70. J Rheumatol. 2006. PMID: 16583479

10

A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases.

Körbelin J, Dogbevia G, Michelfelder S, Ridder DA, Hunger A, Wenzel J, Seismann H, Lampe M, Bannach J, Pasparakis M, Kleinschmidt JA, Schwaninger M, Trepel M. Körbelin J, et al. Among authors: kleinschmidt ja. EMBO Mol Med. 2016 Jun 1;8(6):609-25. doi: 10.15252/emmm.201506078. Print 2016 Jun. EMBO Mol Med. 2016. PMID: 27137490 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page